Avik Pal, Founder and CEO of CliniOps, a technology and data company with multiple patents to digitize global clinical trials. When Michael J. Fox and Stephen Hawking publicly shared their personal ...

Breast cancer is the most-researched disease, yet only 14% of trials reach optimal enrollment, highlighting a significant gap in clinical trial participation. COVID-19 has increased trial attrition ...

Deloitte’s patient engagement platform suite ConvergeHealth on Feb. 18 launched a new digital platform on Amazon Web Services that connects patients and investigators with clinical research trials.

BOWIE, Md.--(BUSINESS WIRE)--Inovalon, a leading provider of cloud-based software solutions empowering data-driven healthcare, today announced the launch of Clinical Research Patient Finder, an ...

Driving Knowledge to Action: Building a Better Future With Artificial Intelligence–Enabled Multidisciplinary Oncology The field of rare cancer research is rapidly transforming, marked by significant ...

DUBLIN--(BUSINESS WIRE)--The "Artificial Intelligence-based Clinical Trial Solutions for Patient Matching - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering ...

Health tech company Inato developed an AI-powered patient prescreening tool to make it easier and faster for research sites to assess patient eligibility for clinical trial opportunities. Launched in ...

Participation in Electronic Patient-Reported Outcome Measures Collection as a Part of Routine Supportive Care Delivery in Oncology An electronic survey was administered to first-time telemedicine ...

What happens to a patient after I refer them to a clinical trial? Do they leave my practice? Referring patients to a clinical trial is similar to referring them to a specialist. They remain your ...

NEO100-01, an intranasal perillyl alcohol therapy, targets IDH1-mutant astrocytomas, aiming to bypass the blood-brain barrier. The phase 2a trial is nearing full enrollment, conducted at seven U.S.